A Phase 2 Trial of Tobevibart plus Elebsiran in Hepatitis D. (nejm.org)

Authors: Asselah T … Agarwal K Journal: New England Journal of Medicine Published: 2026-01-22 DOI: https://doi.org/10.1056/NEJMoa2508827